WO2022000053A1 - Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition - Google Patents
Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition Download PDFInfo
- Publication number
- WO2022000053A1 WO2022000053A1 PCT/BR2020/050236 BR2020050236W WO2022000053A1 WO 2022000053 A1 WO2022000053 A1 WO 2022000053A1 BR 2020050236 W BR2020050236 W BR 2020050236W WO 2022000053 A1 WO2022000053 A1 WO 2022000053A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- mixtures
- total weight
- cosmetic sunscreen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Definitions
- COSMETIC SUNSCREEN COMPOSITION USE OF A COSMETIC SUNSCREEN COMPOSITION, AND PROCESSES FOR MANUFACTURING A COSMETIC
- the present invention is directed to new cosmetic sunscreen compositions with high Sun Protection Factor (SPF), antiwrinkles and anti-spots efficacy, which may or may not tint the skin, comprising at least one UV filter, at least one active compound and at least one polymer.
- SPF Sun Protection Factor
- the present invention is also directed to the use of a cosmetic sunscreen composition, and to a process for manufacturing a cosmetic sunscreen composition.
- UVA/UVB cosmetic sunscreen compositions used to accomplish photoprotection, namely, inorganic UV filters and organic UV filters.
- the mechanism of melanogenesis that is, the mechanism of melanin formation is particularly complex, and schematically involves the following main steps:
- Tyrosine is involved in the mechanism of skin pigmentation, which schematically involves the following main steps:
- Tyrosinase is the essential enzyme involved in these reactions. In particular, it catalyzes the conversion reaction of tyrosine to DOPA (dihydroxyphenylalanine) thanks to its hydroxylase activity, and the conversion reaction of DOPA to dopaquinone by virtue of its oxidase activity. This tyrosinase only acts when it is maturing under the influence of certain biological factors.
- DOPA dihydroxyphenylalanine
- UVA radiation can have a significant contribution to the clinical consequences of solar UV exposure, particularly the pigmentation caused by the solar radiation.
- UVA induces immediate pigment darkening (IPD) within a short time, as little as a few hours, by acting on preexisting melanin. UVA can also cause persistent pigment darkening (PPD) in the skin. Among the UV wavelengths reaching the Earth surface, longwave UVA (340- 400nm) represents up to 80% of total UV and show high penetration properties, reaching the deep dermis.
- IPD immediate pigment darkening
- PPD persistent pigment darkening
- UVA reaches the dermal layers of the skin and its effects on photo aging and keratinocyte invasiveness, melanocytes seem to be more susceptible to the damaging effects of UVA. For example, exposure of cultured melanocytes and keratinocytes from the same donor to UVA and UVB showed that UVA-induced oxidative lesions contributed to a larger extent to DNA damage in melanocytes than in keratinocytes.
- the degree of UV protection afforded by a cosmetic sunscreen composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection (UVA/UVB).
- cosmetic sunscreen compositions must provide good protection against the sun, a measure of which is the Sun Protection Factor (SPF) value, yet have satisfactory sensory perception, such as a smooth but not greasy feel upon application.
- SPF Sun Protection Factor
- sunscreen filters are oil-like and/or oil-soluble materials. High levels of sunscreen filters in sunscreen products render the products less appealing for their greasy skin feel, stickiness, long drying time, and leave shiny residue on the skin after application. The filters also have the tendency to whiten the skin after application and after becoming wet with water or perspiration which is an undesirable attribute.
- an important problem of cosmetic sunscreen compositions is that due to the great amount of sunscreen filters associated with great amount of fillers to ensure the good sensoriality and pigments in the O/W emulsion, it tends to be unstable.
- a cosmetic sunscreen composition that not only confers photoprotection of keratinous materials, but also provides additional properties.
- a cosmetic sunscreen composition with high SPF, antiwrinkles and anti-spots efficacy, which may or may not be able to tint the skin is desired, which is stable and does not feel heavy on the consumer’s skin.
- the inventors of the present application have surprisingly managed to develop a cosmetic sunscreen composition with high SPF, antiwrinkles and anti-spots efficacy, which may or may not be able to tint the skin, while the formula had good sensorial attributes and stability.
- the present invention is directed to new cosmetic sunscreen compositions with high SPF, antiwrinkles and anti-spots efficacy, which may or may not tint the skin, comprising at least one UV filter, at least one active compound and at least one polymer.
- the present invention is also directed to the use of a cosmetic sunscreen composition, and to a process for manufacturing a cosmetic sunscreen composition.
- the cosmetic sunscreen composition of the present invention comprises:
- UV filter selected from octocrylene, terephthalylidene dicamphor sulfonic acid, butyl methoxydibenzoylmethane, drometrizole trisiloxane, ethylhexyl triazone and mixtures thereof;
- the amount of the at least one UV filter ranges from about 5.0 to about 20.0 %, from about 6.0 to about 19.0 %, from about 7.0 to about 18.0 %, from about 8.0 to about 17.0 %, from about 9.0 to about 16.0 %, from about 10.0 to about 17.0%, from about 10.0 to about 15.0 %, from about 11 .0 to about 14.0 %, from about 12.0 to about 15.0 %, from about 14.0 to about 17.0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition.
- the amount of the at least one active compound ranges from about 0.1 to about 10.0 %, from about 0.5 to about 10.0 %, from about 0.75 to about 9.0 %, from about 1 .0 to 7.5 %, from about 2.0 to about 8.0 %, from about 2.5 to about 6.0 %, from about 4.0 to about 5.0 %, from about 0.8 to about 5.0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition.
- the amount of the at least one polymer ranges from about 1 .5 to about 5.0 %, from about 2.0 to about 4.5 %, from about 2.5 to about 4.0 % by weight, from about 3.0 to about 3.5 %, including all ranges and sub ranges there between, based on the total weight of the composition.
- the cosmetic sunscreen composition of the present invention further comprises from about 5.0 to about 15.0 %, preferably from about 6.0 to about 14.0 %, from about 7.0 to about 13.0 %, from about 8.0 to about 12.0 %, from about 9.0 to about 11 .0 % by weight, including all ranges and sub-ranges there between, based on the total weight of the composition, of at least one pigment selected from titanium dioxide, iron oxides, and mixtures thereof.
- the cosmetic sunscreen composition of the present invention further comprises cosmetically acceptable ingredients selected from perfume/fragrance, polymers, preserving agents, solvents, additional actives, surfactants, fat materials, vitamins, fillers and mixtures thereof.
- the cosmetic sunscreen composition of the present invention presents a Sun Protection Factor (SPF) ranging from 30 to 80, preferably from 40 to 70, more preferably about 50.
- SPF Sun Protection Factor
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65, 70 and 80.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 50.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 60.
- cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 70.
- the cosmetic sunscreen composition of the present invention may present a Sun Protection Factor of 80.
- the cosmetic sunscreen composition of the present invention is in the form of an oil in water (O/W) emulsion.
- the cosmetic sunscreen composition of the present invention can be used as a daily product for the skin.
- the present invention also relates to the use of said cosmetic sunscreen composition for manufacturing a product for the photoprotection of keratinous materials with high SPF, antiwrinkles and anti-spots efficacy.
- the expression “at least” means one or more and thus includes individual components as well as mixtures/combinations.
- anti-spots relates to the brightening of pigmented spots or melasma (skin discoloration) for an even-toned skin. Synonyms may include “skin bleaching”, “depigmentation”, “skin tone correction”, among others.
- ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges.
- a range from 1 -5 includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc.
- All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
- compositions and methods of the present disclosure can comprise, consist of, or consist essentially of the essential elements and limitations of the disclosure described herein, as well as any additional or optional ingredients, components, or limitations described herein or otherwise useful.
- the expression “at least one” is interchangeable with the expression “one or more” and thus includes individual components as well as mixtures/combinations.
- a “an,” and “the” are understood to encompass the plural as well as the singular.
- the term “a mixture thereof” also relates to “mixtures thereof.”
- the term “a mixture thereof” is used, following a list of elements as shown in the following example where letters A-F represent the elements: “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture thereof.”
- the term, “a mixture thereof does not require that the mixture include all of A, B, C, D, E, and F (although all of A, B, C, D, E, and F may be included). Rather, it indicates that a mixture of any two or more of A, B, C, D, E, and F can be included. In other words, it is equivalent to the phrase “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture of any two or more of A, B, C, D, E, and F.”
- “Substituted,” as used herein, means comprising at least one substituent.
- substituents include atoms, such as oxygen atoms and nitrogen atoms, as well as functional groups, such as hydroxyl groups, ether groups, alkoxy groups, acyloxyalkyl groups, oxyalkylene groups, polyoxyalkylene groups, carboxylic acid groups, amine groups, acylamino groups, amide groups, halogen containing groups, ester groups, thiol groups, sulphonate groups, thiosulphate groups, siloxane groups, and polysiloxane groups.
- the substituent(s) may be further substituted.
- a salt thereof also relates to “salts thereof.”
- the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A,
- B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included, or a mixture of any two of A, B,
- C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.
- the salts referred to throughout the disclosure may include salts having a counter-ion such as an alkali metal, alkaline earth metal, or ammonium counter-ion. This list of counter-ions, however, is non-limiting.
- compositions of the instant disclosure can be free or essentially free of all components and elements positively recited throughout the instant disclosure.
- the cosmetic sunscreen composition of the present invention may further comprise additional UV filters.
- the concentration of additional sunscreen/UV filters in the system may be between about 5 % to about 35 %, preferably between about 7 % to about 30 % and even more preferably between about 10 % to about 29 % by weight of the total weight of the composition.
- Additional non-limiting suitable UV filters of the present invention could be as follows:
- oil-soluble organic sunscreen ingredient means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
- Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP893119; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as
- cinnamic derivatives include, but are not limited to, ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
- Dibenzoylmethane derivatives examples include, but are not limited to, isopropyl dibenzoylmethane.
- suitable salicylic derivatives include, but are not limited to, homosalate, ethylhexyl salicylate, dipropylene glycol salicylate and TEA salicylate.
- Beta, beta -Diphenylacrylate derivatives
- beta, beta -diphenylacrylate derivatives examples include, but are not limited to, etocrylene.
- benzophenone derivatives include, but are not limited to, benzophenone-1 , benzophenone-2, benzophenone-3 or oxybenzone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, n-hexyl 2-(4-diethylamino-2- hydroxybenzoyl)benzoate or as a mixture with octyl methoxycinnamate.
- Suitable benzylidenecamphor derivatives include, but are not limited to, 3-benzylidene camphor manufactured, 4-methylbenzylidene camphor, polyacrylamidomethyl benzylidene camphor manufactured.
- Suitable phenylbenzotriazole derivatives include, but are not limited to, methylene bis-benzotriazolyl tetramethylbutyl-phenol, or in micronized form as an aqueous dispersion.
- triazine derivatives include, but are not limited to, bis-ethylhexyloxyphenol methoxyphenyl triazine, diethylhexyl butamido triazone, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s-triazine, 2,4,6-tris(diisobutyl 4’- aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'-aminobenzalmalonate)-6-(n- butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents described in patent US 6,225,467, patent application WO 2004/085412 (see compounds 6 and 9) or the document "Symmetrical Triazine Derivatives" IP.COM Journal, IP.COM Inc., West Henrietta, NY, US (20 September 2004), especially 2,4,6-tris(
- An example of a suitable anthranilic derivative includes, but is not limited to, methyl anthranilate.
- An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
- benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15.
- An example of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
- benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl) imino-1 ,3,5-triazine, and mixtures thereof.
- the oil-soluble organic sunscreen ingredient will be chosen from ethylhexyl salicylate, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
- the oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
- the “water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
- Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, phenylbenzimidazole sulfonic acid, benzophenone-4, aminobenzoic acid (PABA), 4-Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated by reference; and cinnamido amine cationic quaternary salts and derivatives such as those described in United
- the salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminum, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2- hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2-hydroxyethyl)amine; lysine or arginine salts.
- Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used.
- the sodium salt is preferably used.
- the water-soluble organic sunscreen ingredient will be chosen from methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
- the water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1% to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1% to about 7% by weight, based on the total weight of the composition.
- the “silica-coated titanium dioxide sunscreen ingredient” means spherical beads which are formed by encapsulating titanium dioxide particles in silica.
- Non-limiting examples of silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica: titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
- silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as name silica (and) titanium dioxide having a composition of silica: titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
- the silica-coated titanium dioxide sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 1% to about 10% by weight, preferably in an amount of from about 2% to about 10% by weight, and most preferably about 5% to about 10% by weight, based on the total weight of the composition.
- the cosmetic sunscreen composition of the present invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, preserving agents, solvents, actives, surfactants, fatty compounds, vitamins, fillers, silicones, polymers, pigments and mixtures thereof.
- the cosmetic sunscreen composition of the present invention comprises water.
- the water used may be sterile demineralized water and/or deionized water and/or a floral water such as rose water, cornflower water, chamomile water or lime water, and/or a natural thermal or mineral water such as, for example: water from Vittel, water from the Vichy basin, water from Uriage, water from La Roche Posay, water from La Bourboule, water from Enghien-les-Bains, water from Saint Gervais-les-Bains, water from Neris-les-Bains, water from Allevar-les-Bains, water from Digne, water from Maizieres, water from Neyrac-les-Bains, water from Lons-le-Saunier, water from EauxBonnes, water from Rochefort, water from Saint Christau, water from Les Fumades, water from Tercis-les-Bains or water from Avene.
- Water may also comprise reconstituted thermal water, that is to say a water comprising trace elements such as
- Suitable polymers include, but are not limited to, acrylates/Cio-3o alkyl acrylate crosspolymer, styrene/acrylates copolymer, and mixtures thereof.
- the composition may also comprise at least one silicon ingredient, which may be dimethicone and caprylyl methicone, among others.
- Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
- Additional suitable solvents include, but are not limited to, C12-15 alkyl benzoate, pentylene glycol, caprylyl glycol, and mixtures thereof.
- Adequate surfactants may be selected from potassium cetyl phosphate, sodium methyl stearoyl taurate and inulin lauryl carbamate, among others.
- the solvent is present in a concentration from about 15 to 100% by weight, or from about 25 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 40 to about 60% by weight, including ranges and sub-ranges therebetween, based on the total weight of the combinations and/or compositions of the present disclosure.
- Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
- the composition may comprise at least one dye/pigment, preferably titanium oxide or iron oxides.
- Exemplary fat or oil materials include, but are not limited to, isopropyl lauroyl sarcosinate, stearyl alcohol, and mixtures thereof.
- the composition may also comprise at least one filler, such as silica or polylactic acid.
- the additional ingredients may represent from 50% to 85%, such as from 55% to 82% or such as from 60 to 80% by weight of the total weight of the composition.
- a non-limiting example regarding the preparation of the cosmetic sunscreen composition according to the present invention could be as follows:
- An example of a suitable cosmetic sunscreen composition according to the present invention comprises:
- Another suitable cosmetic sunscreen composition according to the present invention comprises:
- additional cosmetically acceptable ingredients such as vitamins, fillers, fatty compounds, fragrances, triethanolamine and disodium EDTA;
- An additional suitable cosmetic sunscreen composition according to the present invention comprises:
- Example 1 A suitable composition according to the state of the art is as Example 1 and a suitable cosmetic sunscreen composition according to the present invention is as Examples 2 to 5, as follows:
- the product was used during 28 days by the 50 adults, with all phototypes, with 2 visits (first day, DO and last day, D28). Each subject was her/his own control (comparison between before and after application).
- the application of the cosmetic sunscreen composition of the present invention was performed by the subjects themselves, according to instructions provided by the team and presented on the subject’s diary.
- composition according to Example 3 is cutaneous safe.
- the product has a light texture, has pleasant texture, does not leave the skin shiny, does not leave the skin oily, is quickly absorbed, does not leave the skin sticky, makes the skin more radiant/luminous, disguises the visible pores, gives a comfort touch, brightens the skin, the skin looks more uniform, leaves the skin softer, the skin feels more moisturized immediately after application, the skin feels moisturized throughout the day, the product plumps the skin, leaves the skin firmer, is easy to spread, does not clog pores and has a pleasant odor.
- the cosmetic sunscreen composition of the present invention according to Examples 2 and 3 and a control composition were applied to filter discs of a contact test (patch test) and then fixed on the right or left back (scapular area) of the volunteers, which was allowed to stay on the volunteer’s skin until removal by a trained professional and the area received ultraviolet irradiation A and B.
- Dermatological clinical evaluation was carried out at the beginning and at the end of the study and the volunteers were accompanied by a dermatologist throughout the research.
- the cosmetic sunscreen composition of the present invention was considered safe under the conditions evaluated.
- the cosmetic sunscreen compositions of the present invention according to Example 2 was applied on the subject's dry skin and irradiated with a controlled dose of ultraviolet radiation. Then, the cosmetic sunscreen composition of the present invention was applied to another site, and after a period of 40 minutes, during which the study subject remained in a bathtub, the irradiation was repeated. The sites were evaluated after a period of 16-24 hours.
- the mean static SPF of the cosmetic sunscreen composition of Example 3 was 62.0, and after immersion was 24.8.
- the cosmetic sunscreen composition of Example 2 demonstrated a PF-
- the cosmetic sunscreen compositions of the present invention according to Examples 2 to 5 had very good consumer results, with high approval in all evaluated criteria.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020237003080A KR102861240B1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of cosmetic sunscreen composition, and method for preparing cosmetic sunscreen composition |
| BR112022021113-9A BR112022021113B1 (en) | 2020-06-30 | COSMETIC SUN PROTECTION COMPOSITION WITH HIGH SPF, USE OF A COSMETIC SUN PROTECTION COMPOSITION AND PROCESSES FOR MANUFACTURING A COSMETIC SUN PROTECTION COMPOSITION | |
| PCT/BR2020/050236 WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
| CN202080102545.7A CN116710054A (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition and method for producing a cosmetic sunscreen composition |
| FR2008769A FR3111809B1 (en) | 2020-06-30 | 2020-08-28 | Photoprotective cosmetic composition, use of a photoprotective cosmetic composition and process for manufacturing a photoprotective cosmetic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2020/050236 WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022000053A1 true WO2022000053A1 (en) | 2022-01-06 |
Family
ID=71574899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BR2020/050236 Ceased WO2022000053A1 (en) | 2020-06-30 | 2020-06-30 | Cosmetic sunscreen composition, use of a cosmetic sunscreen composition, and processes for manufacturing a cosmetic sunscreen composition |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR102861240B1 (en) |
| CN (1) | CN116710054A (en) |
| FR (1) | FR3111809B1 (en) |
| WO (1) | WO2022000053A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025178141A1 (en) | 2024-02-20 | 2025-08-28 | L'oreal | Sun care composition |
| FR3160327A3 (en) | 2024-03-22 | 2025-09-26 | L'oreal | SUN CARE COMPOSITION |
| WO2025215221A1 (en) * | 2024-04-11 | 2025-10-16 | L'oreal | Composition comprising drometrizole trisiloxane, a hydrophilic organic screening agent, with a hydrophilic organic screening agents/lipophilic organic screening agents mass ratio of greater than 0.3, and which is alcohol-free |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102664351B1 (en) * | 2023-05-23 | 2024-05-08 | 한국콜마주식회사 | Sun screening cosmetic composition comprising a sunscreen material composed of an organic-inorganic composite |
Citations (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
| US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
| WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
| US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
| EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
| US5601811A (en) | 1994-08-01 | 1997-02-11 | Croda, Inc. | Substantive water-soluble cationic UV-absorbing compounds |
| GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
| US5624663A (en) | 1987-08-28 | 1997-04-29 | L'oreal | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates |
| EP0832642A2 (en) | 1996-09-13 | 1998-04-01 | 3V SIGMA S.p.A | Derivatives of Benzoxazole useful as uv filters |
| DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
| EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| DE19746654A1 (en) | 1997-08-13 | 1999-02-18 | Basf Ag | Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds |
| DE19755649A1 (en) | 1997-12-15 | 1999-06-17 | Basf Ag | Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics |
| EP0967200A1 (en) | 1998-06-26 | 1999-12-29 | Basf Aktiengesellschaft | 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations |
| DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
| EP1008586A1 (en) | 1998-12-11 | 2000-06-14 | Basf Aktiengesellschaft | Oligomeric diarylbutadienes |
| EP1027883A2 (en) | 1999-01-11 | 2000-08-16 | 3V SIGMA S.p.A | Combinations of sunscreen agents with UV-A and UV-B filtering properties |
| US6225467B1 (en) | 2000-01-21 | 2001-05-01 | Xerox Corporation | Electroluminescent (EL) devices |
| EP1133980A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations |
| EP1133981A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations |
| EP1300137A2 (en) | 2001-10-02 | 2003-04-09 | 3V SIGMA S.p.A | Combinations of sunscreens |
| DE10162844A1 (en) | 2001-12-20 | 2003-07-03 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives |
| WO2004006878A1 (en) | 2002-07-10 | 2004-01-22 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
| WO2004085412A2 (en) | 2003-03-24 | 2004-10-07 | Ciba Specialty Chemicals Holding Inc. | Symmetrical triazine derivatives |
| WO2005058269A1 (en) | 2003-12-17 | 2005-06-30 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
| WO2006032741A1 (en) | 2004-09-20 | 2006-03-30 | L'oréal | Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter |
| WO2006034985A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate |
| WO2006034982A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Light-block concentrate with organic micropigments |
| WO2006035007A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic light-block preparation made from micropigments |
| WO2006035000A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Sun protection emulsion comprising a high fraction of sun protection filter pigments |
| WO2006034991A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | W/o emulsion comprising uv filter pigments |
| WO2006034992A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic sunscreen emulsions containing organic micropigments |
| EP1990372A2 (en) | 2007-05-09 | 2008-11-12 | Ciba Holding Inc. | Water soluble UV filters |
| WO2018000060A1 (en) * | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
| WO2020000071A1 (en) * | 2018-06-29 | 2020-01-02 | L'oreal | Customized color shade sunscreen products |
| WO2020024022A1 (en) * | 2018-07-31 | 2020-02-06 | L'oreal | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2833167B1 (en) * | 2001-12-07 | 2004-05-21 | Oreal | ANTISOLAR COSMETIC COMPOSITIONS BASED ON A SYNERGISTIC MIXTURE OF FILTERS AND USES |
| FR2939669B1 (en) * | 2008-12-17 | 2011-03-25 | Oreal | COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions. |
-
2020
- 2020-06-30 CN CN202080102545.7A patent/CN116710054A/en active Pending
- 2020-06-30 WO PCT/BR2020/050236 patent/WO2022000053A1/en not_active Ceased
- 2020-06-30 KR KR1020237003080A patent/KR102861240B1/en active Active
- 2020-08-28 FR FR2008769A patent/FR3111809B1/en active Active
Patent Citations (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
| US5624663A (en) | 1987-08-28 | 1997-04-29 | L'oreal | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates |
| US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
| US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
| WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
| EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
| US5601811A (en) | 1994-08-01 | 1997-02-11 | Croda, Inc. | Substantive water-soluble cationic UV-absorbing compounds |
| GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
| EP0832642A2 (en) | 1996-09-13 | 1998-04-01 | 3V SIGMA S.p.A | Derivatives of Benzoxazole useful as uv filters |
| DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
| EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| DE19746654A1 (en) | 1997-08-13 | 1999-02-18 | Basf Ag | Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds |
| DE19755649A1 (en) | 1997-12-15 | 1999-06-17 | Basf Ag | Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics |
| EP0967200A1 (en) | 1998-06-26 | 1999-12-29 | Basf Aktiengesellschaft | 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations |
| DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
| EP1008586A1 (en) | 1998-12-11 | 2000-06-14 | Basf Aktiengesellschaft | Oligomeric diarylbutadienes |
| EP1027883A2 (en) | 1999-01-11 | 2000-08-16 | 3V SIGMA S.p.A | Combinations of sunscreen agents with UV-A and UV-B filtering properties |
| US6225467B1 (en) | 2000-01-21 | 2001-05-01 | Xerox Corporation | Electroluminescent (EL) devices |
| EP1133980A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations |
| EP1133981A2 (en) | 2000-03-15 | 2001-09-19 | Basf Aktiengesellschaft | Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations |
| EP1300137A2 (en) | 2001-10-02 | 2003-04-09 | 3V SIGMA S.p.A | Combinations of sunscreens |
| DE10162844A1 (en) | 2001-12-20 | 2003-07-03 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives |
| WO2004006878A1 (en) | 2002-07-10 | 2004-01-22 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
| WO2004085412A2 (en) | 2003-03-24 | 2004-10-07 | Ciba Specialty Chemicals Holding Inc. | Symmetrical triazine derivatives |
| WO2005058269A1 (en) | 2003-12-17 | 2005-06-30 | Ciba Specialty Chemicals Holding Inc. | Merocyanine derivatives for cosmetic use |
| WO2006032741A1 (en) | 2004-09-20 | 2006-03-30 | L'oréal | Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter |
| WO2006034985A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate |
| WO2006034982A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Light-block concentrate with organic micropigments |
| WO2006035007A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic light-block preparation made from micropigments |
| WO2006035000A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Sun protection emulsion comprising a high fraction of sun protection filter pigments |
| WO2006034991A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | W/o emulsion comprising uv filter pigments |
| WO2006034992A1 (en) | 2004-09-27 | 2006-04-06 | Beiersdorf Ag | Cosmetic sunscreen emulsions containing organic micropigments |
| EP1990372A2 (en) | 2007-05-09 | 2008-11-12 | Ciba Holding Inc. | Water soluble UV filters |
| WO2018000060A1 (en) * | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
| WO2020000071A1 (en) * | 2018-06-29 | 2020-01-02 | L'oreal | Customized color shade sunscreen products |
| WO2020024022A1 (en) * | 2018-07-31 | 2020-02-06 | L'oreal | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE GNPD [online] MINTEL; 15 February 2016 (2016-02-15), ANONYMOUS: "Clarify Coloured Gel-Cream SPF 60", XP055784832, retrieved from https://www.gnpd.com/sinatra/recordpage/3799751/ Database accession no. 3799751 * |
| DATABASE GNPD [online] MINTEL; 20 March 2018 (2018-03-20), ANONYMOUS: "Intelligent Anti-Age DNA Defense SPF 100", XP055784849, retrieved from https://www.gnpd.com/sinatra/recordpage/5520865/ Database accession no. 5520865 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025178141A1 (en) | 2024-02-20 | 2025-08-28 | L'oreal | Sun care composition |
| FR3160327A3 (en) | 2024-03-22 | 2025-09-26 | L'oreal | SUN CARE COMPOSITION |
| WO2025215221A1 (en) * | 2024-04-11 | 2025-10-16 | L'oreal | Composition comprising drometrizole trisiloxane, a hydrophilic organic screening agent, with a hydrophilic organic screening agents/lipophilic organic screening agents mass ratio of greater than 0.3, and which is alcohol-free |
| FR3161108A1 (en) * | 2024-04-11 | 2025-10-17 | L'oreal | Composition comprising Drometrizole Trisiloxane, a hydrophilic organic filter, with a mass ratio of hydrophilic organic filters / lipophilic organic filters greater than 0.3, alcohol-free |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3111809B1 (en) | 2023-11-24 |
| BR112022021113A2 (en) | 2023-01-10 |
| KR20230029919A (en) | 2023-03-03 |
| KR102861240B1 (en) | 2025-09-18 |
| CN116710054A (en) | 2023-09-05 |
| FR3111809A1 (en) | 2021-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102861240B1 (en) | Cosmetic sunscreen composition, use of cosmetic sunscreen composition, and method for preparing cosmetic sunscreen composition | |
| EP1317918B1 (en) | Cosmetic sunscreen compositions based on synergistic filter mixture and their use | |
| JP2019059791A (en) | Light protection composition | |
| US20240000677A1 (en) | Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition | |
| FR3001136A1 (en) | COSMETIC OR DERMATOLOGICAL EMULSION COMPRISING A MEROCYANINE AND AN EMULSIFIER SYSTEM CONTAINING AN AMPHIPHILIC POLYMER COMPRISING AT LEAST ONE ACRYLAMIDO 2-METHYLPROPANE SULFONIC ACIDIC PATTERN | |
| WO2011061864A1 (en) | A cosmetic or dermatological composition with low stickiness, containing a lipophilic active ingredient | |
| US20240299280A1 (en) | Sunscreen composition, use of the sunscreen composition and process of manufacturing the sunscreen composition | |
| EP1323412B1 (en) | Light screening composition comprising a dibenzoylmethane type screening agent and an amino substituted 2-hydroxybenzophenone derivative | |
| FR3073409B1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN ACRYLIC POLYMER. | |
| JP6509743B2 (en) | Cosmetic or dermatological composition comprising a merocyanine, an organic UVB screening agent and an additional organic UVA screening agent | |
| CA2511078C (en) | Process of photostabilization of a derivative of dibenzoylmethane using an aryl-alkyl benzoate derivative and photoprotective cosmetic compositions | |
| EP3829531B1 (en) | Sun care composition for whitening the skin, use of the sun care composition, and process of manufacture of the sun care composition | |
| EP1323411A1 (en) | Cosmetic sunscreen compositions based on a synergic mixture of screening agents and their uses | |
| WO2022160020A1 (en) | Water-in-oil cosmetic sunscreen composition, use of a water-in-oil cosmetic sunscreen composition, and process for manufacturing a water-in-oil cosmetic sunscreen composition | |
| JP2007204476A (en) | A composition comprising a cinnamic ester type UV-B screening agent, a dibenzoylmethane type UV-A screening agent, and an s-triazine derivative; | |
| JP3893336B2 (en) | Shielding composition containing benzoylmethane derivative and 1,1,3-tris (2-methyl-4-hydroxy-5-tert-butylphenyl) butane | |
| EP1370233B1 (en) | Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound | |
| JP6487337B2 (en) | Cosmetic or dermatological composition comprising merocyanine and insoluble organic UV screening agent and / or insoluble inorganic UV screening agent | |
| BR112022021113B1 (en) | COSMETIC SUN PROTECTION COMPOSITION WITH HIGH SPF, USE OF A COSMETIC SUN PROTECTION COMPOSITION AND PROCESSES FOR MANUFACTURING A COSMETIC SUN PROTECTION COMPOSITION | |
| FR3075050A1 (en) | COMPOSITION COMPRISING BAICALIN AND ANTIOXIDANT COMPOUND | |
| EP1370231B1 (en) | Filtering composition containing a filter of the type derived from dibenzoylmethane and a 4,4-diarylbutadiene type filter | |
| EP1618868B1 (en) | Process for photostabilising a dibenzoylmethane derivative with an arylalkyl benzoate derivative and a bis-resorcinyl triazine compound and sunscreening cosmetic compositions | |
| WO2025024904A1 (en) | Cosmetic composition, use of the cosmetic composition and process for manufacturing the cosmetic composition | |
| WO2025156021A1 (en) | Tinted sunscreen compositions, process for manufacturing a tinted sunscreen composition, and use of a tinted sunscreen composition | |
| EP1317919A1 (en) | Cosmetic sunscreen compositions based on synergistic filter mixture and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20739248 Country of ref document: EP Kind code of ref document: A1 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022021113 Country of ref document: BR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202080102545.7 Country of ref document: CN |
|
| ENP | Entry into the national phase |
Ref document number: 112022021113 Country of ref document: BR Kind code of ref document: A2 Effective date: 20221018 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20739248 Country of ref document: EP Kind code of ref document: A1 |